young-people-at-work

Physical, Biological and Chemical Agents & Processes and Work

EU. Non-Exhaustive List of Banned Substances, Directive 94/33/EC on Young People at Work, 20 August 1994, as amended by Dir 2014/27/EU, March 5, 2014 (Based on Table 3 of Annex VI to CLP, inter alia)

This list contains biological and chemical agents, in accordance with Art. 7 and points 2 and 3 of the Annex to Directive 94/33/EC, to which young persons (under 18 years of age) may not be exposed at the workplace. The list is a non-exhaustive inventory of such substances based on: 1) agents of risk groups 3 and 4 under Directive 2000/54/EC; 2) Table 3 of Annex VI to the CLP Regulation; 3) and Annex I of Directive 2004/37/EC.

Last updated 24 lipnja 2024. Database contains 3522 unique substances/entries.
Filter the list

 
The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.
277-567-8
73665-18-6
Carc. 1B; Muta. 1B
Details
615-273-7
71283-80-2
STOT RE 2; Skin Sens. 1
Details
276-696-7
72490-01-8
Carc. 2
Details
200-990-6
76-87-9
Carc. 2; Acute Tox. 2; Acute Tox. 3; STOT RE 1
Details
616-712-5
79622-59-6
Skin Sens. 1A
Details
231-954-8
7782-41-4
Acute Tox. 2; Skin Corr. 1A
Details
232-149-4
7789-21-1
Skin Corr. 1A
Details
200-842-0
75-12-7
Repr. 1B
Details
278-636-5
77182-82-2
Repr. 1B; STOT RE 2
Details
200-962-3
76-44-8
Carc. 2; Acute Tox. 3; STOT RE 2
Details
201-029-3
77-47-4
Acute Tox. 2; Acute Tox. 3; Skin Corr. 1B
Details
HEXACONAZOLE
413-050-7
79983-71-4
Skin Sens. 1
Details
231-595-7
7647-01-0
Acute Tox. 3; Skin Corr. 1A
Details
231-595-7
7647-01-0
Skin Corr. 1B
Details
231-634-8
7664-39-3
Acute Tox. 2; Acute Tox. 1; Skin Corr. 1A
Details
231-634-8
7664-39-3
Acute Tox. 2; Acute Tox. 1; Skin Corr. 1A
Details
200-821-6
74-90-8
Flam. Liq. 1; Acute Tox. 2
Details
200-821-6
74-90-8
Acute Tox. 2; Acute Tox. 1
Details
231-765-0
7722-84-1
Skin Corr. 1A
Details
231-977-3
7783-06-4
Acute Tox. 2
Details
232-259-2
7803-49-8
Unst. Expl.; Carc. 2; STOT RE 2; Skin Sens. 1
Details
232-259-2
7803-49-8
Carc. 2; STOT RE 2; Skin Sens. 1
Details
428-790-6
72963-72-5
Carc. 2; STOT SE 2
Details
200-857-2
75-28-5
Flam. Gas 1; Carc. 1A; Muta. 1B
Details
200-857-2
75-28-5
Flam. Gas 1
Details
201-194-1
79-30-1
Flam. Liq. 2; Skin Corr. 1A
Details
201-142-8
78-78-4
Flam. Liq. 1
Details
201-143-3
78-79-5
Flam. Liq. 1; Carc. 1B; Muta. 2
Details
201-196-2
79-33-4
Skin Corr. 1C
Details
231-846-0
7758-97-6
Carc. 1B; Repr. 1A; STOT RE 2
Details
232-064-2
7784-40-9
Carc. 1A; Repr. 1A; Acute Tox. 3; STOT RE 2
Details
231-100-4
7439-92-1
yes
Details
231-100-4
7439-92-1
Repr. 1A
Details
231-100-4
7439-92-1
Repr. 1A
Details
201-134-4
78-70-6
Skin Sens. 1B
Details
231-102-5
7439-93-2
Skin Corr. 1B
Details
A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.
278-011-7
74869-21-9
Carc. 1B
Details
A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40°C. It contains a relatively large proportion of saturated hydrocarbons.
276-737-9
72623-86-0
Carc. 1B
Details
A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40°C. It contains a relatively large proportion of saturated hydrocarbons.
276-736-3
72623-85-9
Carc. 1B
Details
A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40°C. It contains a relatively large proportion of saturated hydrocarbons.
276-738-4
72623-87-1
Carc. 1B
Details
A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.
278-012-2
74869-22-0
Carc. 1B
Details
232-089-9
7785-87-7
STOT RE 2
Details
231-106-7
7439-97-6
Repr. 1B; Acute Tox. 2; STOT RE 1
Details
231-299-8
7487-94-7
Muta. 2; Acute Tox. 2; STOT RE 1; Skin Corr. 1B
Details
201-204-4
79-41-4
Skin Corr. 1A
Details
200-812-7
74-82-8
Flam. Gas 1
Details
200-898-6
75-75-2
Skin Corr. 1B
Details
200-822-1
74-93-1
Flam. Gas 1; Acute Tox. 3
Details
F7641; MTSI
410-550-7
79277-18-2
STOT RE 2; Resp. Sens. 1; Skin Sens. 1
Details
BROMBENZOAT; BROMOBENZOATE
410-310-1
70264-94-7
Skin Sens. 1
Details
201-185-2
79-20-9
Flam. Liq. 2
Details
MAGME(R) 200 MONOMER
403-230-3
77402-05-2
Carc. 1B; Muta. 1B; Skin Corr. 1B; Skin Sens. 1
Details
MAGME 100 MONOMEER
401-890-7
77402-03-0
Carc. 1B; Muta. 1B
Details
201-187-3
79-22-1
Flam. Liq. 2; Acute Tox. 2; Skin Corr. 1B
Details
200-819-5
74-88-4
Carc. 2; Acute Tox. 3
Details
232-095-1
7786-34-7
Acute Tox. 1; Acute Tox. 2
Details
200-820-0
74-89-5
Flam. Liq. 1; Skin Corr. 1B
Details
200-820-0
74-89-5
Flam. Gas 1
Details
Z-22
415-880-5
779343-34-9
Skin Sens. 1
Details
200-806-4
74-31-7
Skin Sens. 1
Details
DISPERSOL BLUE C-4G COLOUR; SUBSTANCE H87919
416-860-9
777891-21-1
Skin Sens. 1
Details
BENZANILID-DISPERSE-INTERMEDIATE ZP 9955
411-590-8
70693-57-1
Skin Corr. 1B
Details
DISPERSOL YELLOW XF
407-970-8
75511-91-0
Skin Sens. 1
Details
N-METHYL-4-(P-FORMYLSTYRYL)-PYRIDINIUM METHYLSULFATE; SBQ; SBQ-SALZ
418-240-3
74401-04-0
Skin Sens. 1
Details
201-182-6
79-16-3
Repr. 1B
Details
933-378-9
776297-69-9
Repr. 1B
Details
231-743-0
7718-54-9
Carc. 1A; Muta. 2; Repr. 1B; Acute Tox. 3; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
Details
232-104-9
7786-81-4
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
Details
274-755-1
70692-93-2
Carc. 1A; STOT RE 1; Skin Sens. 1
Details
231-827-7
7757-95-1
Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
Details
231-111-4
7440-02-0
Carc. 2; STOT RE 1; Skin Sens. 1
Details
231-111-4
7440-02-0
Carc. 2; STOT RE 1; Skin Sens. 1
Details
231-714-2
7697-37-2
Acute Tox. 3; Skin Corr. 1A
Details
231-714-2
7697-37-2
Acute Tox. 1; Skin Corr. 1A
Details
DAISO CCS-1S-E; S-GLYTO
417-210-7
70987-78-9
Carc. 1B; Muta. 2; Skin Sens. 1
Details
200-925-1
76-01-7
Carc. 2; STOT RE 1
Details
201-084-3
78-11-5
Unst. Expl.
Details
201-084-3
78-11-5
Expl. 1.1
Details
404-290-3
7216-95-7
Repr. 1B; STOT RE 2
Details
201-186-8
79-21-0
Skin Corr. 1A
Details
231-512-4
7601-90-3
Skin Corr. 1A
Details
616-100-8
74499-35-7
Repr. 1B; Skin Corr. 1C
Details
201-004-7
77-09-8
Carc. 1B; Muta. 2
Details
200-870-3
75-44-5
Acute Tox. 2; Skin Corr. 1B
Details
211-987-4
732-11-6
Acute Tox. 3; STOT SE 1
Details
232-260-8
7803-51-2
Flam. Gas 1; Acute Tox. 1; Skin Corr. 1B
Details
231-633-2
7664-38-2
Skin Corr. 1B
Details
232-178-2
7789-60-8
Skin Corr. 1B
Details
231-749-3
7719-12-2
Acute Tox. 2; STOT RE 2; Skin Corr. 1A
Details
PAA HCL; PAA HCL 10L; PAA HCL 10S; PAA HCL 3L; PAA HCL 3S; PAA HCL H; PAA HCL L
415-050-2
71550-12-4
Skin Sens. 1
Details
231-119-8
7440-09-7
Skin Corr. 1B
Details
232-156-2
7789-29-9
Acute Tox. 3; Skin Corr. 1B
Details
231-829-8
7758-01-2
Carc. 1B; Acute Tox. 3
Details
232-140-5
7789-00-6
Carc. 1B; Muta. 1B; Skin Sens. 1
Details
231-906-6
7778-50-9
Carc. 1B; Muta. 1B; Repr. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1
Details
232-151-5
7789-23-3
Acute Tox. 3
Details
231-594-1
7646-93-7
Skin Corr. 1B
Details
231-832-4
7758-09-0
Acute Tox. 3
Details
231-911-3
7778-73-6
Carc. 2; Acute Tox. 2; Acute Tox. 3
Details
200-746-9
71-23-8
Flam. Liq. 2
Details
200-827-9
74-98-6
Flam. Gas 1
Details
201-176-3
79-09-4
Skin Corr. 1B
Details
201-170-0
79-03-8
Flam. Liq. 2; Skin Corr. 1B
Details
200-879-2
75-56-9
Flam. Liq. 1; Carc. 1B; Muta. 1B; Acute Tox. 3
Details
201-155-9
78-90-0
Skin Corr. 1A
Details
VIKOFLEX 9080
414-890-7
71302-79-9
Skin Sens. 1
Details
277-299-1
73138-82-6
Skin Sens. 1
Details
231-957-4
7782-49-2
Acute Tox. 3; STOT RE 2
Details
231-853-9
7761-88-8
Skin Corr. 1B
Details
231-132-9
7440-23-5
Skin Corr. 1B
Details
426-520-1
71420-85-4
Skin Sens. 1
Details
231-887-4
7775-09-9
Acute Tox. 3
Details
231-889-5
7775-11-3
Carc. 1B; Muta. 1B; Repr. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1
Details
231-667-8
7681-49-4
Acute Tox. 3
Details
231-668-3
7681-52-9
Skin Corr. 1B
Details
274-357-8
70161-44-3
Carc. 1B; Muta. 2; Skin Sens. 1
Details
231-555-9
7632-00-0
Acute Tox. 3
Details
231-556-4
7632-04-4
Repr. 1B; Acute Tox. 3
Details
231-556-4
7632-04-4
Repr. 1B
Details
232-142-6
7789-06-2
Carc. 1B
Details
231-195-2
7446-09-5
Acute Tox. 3; STOT SE 1; Skin Corr. 1B
Details
231-639-5
7664-93-9
Skin Corr. 1A
Details
232-245-6
7791-25-5
Skin Corr. 1B
Details
274-560-1
70321-67-4
Carc. 1B; Muta. 1B
Details
200-927-2
76-03-9
Skin Corr. 1A
Details
616-699-6
79538-32-2
Acute Tox. 1; Acute Tox. 2
Details
231-193-1
7446-07-3
Repr. 1B
Details
212-105-0
762-75-4
Flam. Liq. 2
Details
200-915-7
75-91-2
Muta. 2
Details
231-711-6
7696-12-0
Carc. 2; STOT SE 2
Details
TMAP
416-900-5
79723-02-7
Acute Tox. 3; STOT RE 2
Details
231-138-1
7440-28-0
Acute Tox. 2; STOT RE 2
Details
231-748-8
7719-09-7
Skin Corr. 1A
Details
231-588-9
7646-78-8
Skin Corr. 1B
Details
231-441-9
7550-45-0
Skin Corr. 1B
Details
211-986-9
731-27-1
Skin Sens. 1
Details
211-986-9
731-27-1
Acute Tox. 2; STOT RE 1; Skin Sens. 1
Details
AMINODIOXEPAN
419-050-3
79944-37-9
Skin Sens. 1
Details
200-875-0
75-50-3
Flam. Gas 1
Details
200-875-0
75-50-3
Flam. Liq. 1; Skin Corr. 1B
Details
200-902-6
75-79-6
Flam. Liq. 2
Details
201-167-4
79-01-6
Carc. 1B; Muta. 2
Details
200-930-9
76-06-2
Acute Tox. 2
Details
200-929-3
76-05-1
Skin Corr. 1A
Details
231-205-5
7446-27-7
Repr. 1A; STOT RE 2
Details
-
74646-29-0
Carc. 1A; STOT RE 1; Skin Sens. 1
Details
231-170-6
7440-61-1
Acute Tox. 2; STOT RE 2
Details
200-831-0
75-01-4
Flam. Gas 1; Carc. 1A
Details
231-592-0
7646-85-7
Skin Corr. 1B
Details
SQ 26999
412-170-7
83623-61-4
STOT RE 2; Skin Sens. 1
Details
433-520-5
82911-69-1
Skin Sens. 1
Details
DWS
404-940-6
86608-70-0
STOT RE 2
Details
284-351-7
84852-39-1
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
Details
287-470-2
85508-45-8
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
Details
201-501-9
83-79-4
Acute Tox. 3
Details
SULPHONAMIDO-ANILINE
406-010-5
88918-84-7
Skin Sens. 1
Details
SULPHAZINE
406-090-1
81880-96-8
Muta. 2; Acute Tox. 3; STOT RE 1; Skin Sens. 1
Details
420-450-5
86552-32-1
Carc. 2
Details
CP-166,221
428-010-4
82413-20-5
Carc. 2; Repr. 1B; Skin Sens. 1
Details
284-348-0
84852-36-8
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
Details
285-909-2
85166-19-4
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
Details
287-471-8
85508-46-9
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
Details
287-592-6
85551-28-6
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
Details
284-347-5
84852-35-7
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
Details
445-750-3
839705-03-2
Skin Sens. 1
Details
811-718-6
86347-14-0
Acute Tox. 2; STOT SE 1; STOT RE 1
Details
C.I. REAKTIV-BLAU 216; KAYACELON REACT BLUE CN-BL; KAYACELON REAKT-BLAU CN-BL; UBCNBL
404-670-9
89797-01-3
Skin Sens. 1
Details
281-291-3
83918-57-4
Skin Corr. 1B; Skin Sens. 1
Details
281-291-3
83918-57-4
Skin Sens. 1
Details
212-557-9
826-62-0
Resp. Sens. 1; Skin Sens. 1
Details
201-605-4
85-43-8
Resp. Sens. 1; Skin Sens. 1
Details
284-032-2
84777-06-0
Repr. 1B
Details
DCEMH
401-570-7
89415-87-2
Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1
Details
4-(4-BUTYLCYCLOHEXYL)-ACETOPHENON
427-320-7
83626-30-6
Skin Sens. 1
Details
GM 102 E
411-370-1
82857-68-9
Acute Tox. 3
Details
201-800-4
88-12-0
Carc. 2; STOT RE 2
Details
EPIKOTE YX4000; EPIKOTE YX4000H; YX-4000
413-900-7
85954-11-6
Carc. 2; Skin Sens. 1
Details
CIN 10096132; MTI
407-630-9
82633-79-2
Acute Tox. 3; Skin Sens. 1
Details
201-795-9
88-06-2
Carc. 2
Details
201-865-9
88-89-1
Expl. 1.1; Acute Tox. 3
Details
201-436-6
82-71-3
Expl. 1.1
Details
428-390-1
86393-34-2
Skin Sens. 1
Details
UK-51,060-01
412-390-3
86386-75-6
Skin Sens. 1
Details
201-758-7
87-62-7
Carc. 2
Details
EPO
411-210-0
89544-48-9
Skin Sens. 1
Details
5-CHLOR-2-PENTANON-NEOPENTYLKETAL; 5-CHLORO-2-PENTANONE-NEOPENTYLKETAL; CHLORKETAL
417-650-1
88128-57-8
STOT RE 2
Details
201-289-8
80-54-6
Repr. 1B
Details
MCPSI
410-900-9
83056-32-0
Muta. 2; STOT RE 2; Resp. Sens. 1
Details
JEFFCAT ZF-10; TEXACAT ZF-10
406-080-7
83016-70-0
Skin Corr. 1B
Details
2-BUTYL-4-CHLORO-5-FORMYLIMIDAZOLE; BCFI
410-260-0
83857-96-9
Skin Sens. 1
Details
201-864-3
88-88-0
Expl. 1.1; Acute Tox. 2; Acute Tox. 1
Details
201-956-3
89-98-5
Skin Corr. 1B
Details
285-698-7
85135-77-9
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
Details
279-452-8
80387-97-9
Repr. 1B; Skin Sens. 1
Details
212-454-9
818-61-1
Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1
Details
212-782-2
868-77-9
Skin Sens. 1
Details
212-513-9
823-40-5
Muta. 2; Skin Sens. 1
Details
201-853-3
88-72-2
Carc. 1B; Muta. 1B
Details
128719
401-460-9
82560-06-3
Acute Tox. 3
Details
421-310-6
87691-88-1
Skin Sens. 1
Details

Export search results to: